SSR 125543A

SSR 125543A Suppliers list
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: ChengDu TongChuangYuan Pharmaceutical Co.Ltd  
Tel: 028-83379370 13880556291
Email: tcy@tcypharm.com
Company Name: CONIER CHEM AND PHARMA LIMITED  
Tel:
Email: sales@conier.com
Company Name: Guangzhou Younan Technology Co., Ltd  
Tel: 020-82000279 18988941452
Email: YN_research@163.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com

SSR 125543A manufacturers

SSR 125543A Basic information
Product Name:SSR 125543A
Synonyms:SSR 125543A;SSR-125543 hydrochloride;Crinecerfont;Crinecerfont hydrochloride
CAS:321839-75-2
MF:C27H29Cl2FN2OS
MW:519.5
EINECS:
Product Categories:
Mol File:321839-75-2.mol
SSR 125543A Structure
SSR 125543A Chemical Properties
storage temp. 4°C, away from moisture and light
solubility DMSO: 2 mg/mL, clear
form Solid
color Light yellow to yellow
Safety Information
MSDS Information
SSR 125543A Usage And Synthesis
UsesCrinecerfont (SSR-125543) hydrochloride is a potent, orally active, non-peptide CRF1 receptor antagonist. Crinecerfont can be used for Classic congenital adrenal hyperplasia (CAH) research[1]. Crinecerfont (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
References[1] Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia (CAHtalyst).
SSR 125543A Preparation Products And Raw materials
Tag:SSR 125543A(321839-75-2) Related Product Information
CRF1 receptor antagonist-1 4-(2-chloro-4-Methoxy-5-Methyl-phenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-Methyl-phenyl)ethyl]-5-Methyl-N-prop-2-ynyl-1,3-thiazol-2-aMine 2-Thiazolamine, 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-2-propyn-1-yl-, compd. with 4-methylbenzenesulfonate (1:1) 2-Thiazolamine, 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1R)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-2-propyn-1-yl- SSR 125543A 13H-17,20-Methano-8,12-nitrilo-12H-pyrido[3,2-d][1,2,6,13]thiatriazacyclooctadecin-5(6H)-one, 2-[3-(2-dispiro[2.0.2.1]hept-7-ylethoxy)-1H-pyrazol-1-yl]-14,15,16,17,18,19-hexahydro-19,19-dimethyl-, 7,7-dioxide, (17S)-